Anthera Pharmaceuticals
NASDAQ:ANTH (6/27/2018, 7:28:13 PM)
After market: 0.12 +0 (+2.56%)0.117
-0.15 (-56.67%)
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing products to treat serious illnesses, including cardiovascular and autoimmune diseases. The Company's clinical-stage programs include one Phase 3 ready program, A-002, and two Phase 2 clinical programs, A-623 and A-001. A-002 and A-001 inhibit a novel enzyme target known as secretory phospholipase A2, or sPLA2. Elevated levels of sPLA2 have been implicated in a variety of acute inflammatory conditions, including acute coronary syndrome and acute chest syndrome, as well as chronic diseases such as stable coronary artery disease. A-623 targets elevated levels of B-lymphocyte stimulator, or BLyS (also known as BAFF), which has been associated with a variety of B-cell mediated autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis, multiple sclerosis, Sj'gren's Syndrome, Graves' Disease and others. Anthera Pharmaceuticals, Inc. is headquartered in Hayward, California.
Anthera Pharmaceuticals
25801 INDUSTRIAL BOULEVARD SUITE B
HAYWARD CA 94545
P: 510-856-5600
CEO: J. Craig Thompson
ROSE – ROSE leads the way today as the best performing small cap stock, closing up 57.58%.
SHIP – SHIP leads the way today as the best performing small cap stock, closing up 1,257.87%.
PDSB – PDSB leads the way today as the best performing small cap stock, closing up 60.49%.
WAFU – WAFU leads the way today as the best performing small cap stock, closing up 222.07%.
YAYO – YAYO leads the way today as the best performing small cap stock, closing up 39.78%.
Here you can normally see the latest stock twits on ANTH, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: